Medicxi

Medicxi is a European investment firm dedicated to the life sciences sector, specializing in the creation, investment, and support of biotech companies across the full drug development spectrum. The firm employs an asset-centric financing model, focusing on novel biological insights and backing entrepreneurial scientists to streamline therapeutic innovation from discovery to market.

The firm was established in 2016 by the former life sciences team of Index Ventures. This experienced team leveraged over two decades in drug discovery and developing therapeutics for unmet medical needs, driven by the insight that a focused investment model could accelerate early-stage scientific breakthroughs by reducing complexities.

Medicxi targets biotech ventures poised to deliver novel therapies to patients in need. Their vision is to foster impactful innovation, guiding portfolio companies from initial scientific proof-of-concept to pivotal studies, regulatory approvals, and ultimately market launch, ensuring medical advancements reach those who benefit.